Tiletamine

32 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

940.0%

Death Rate

Active Ingredients

Tiletamine

Administration Routes

UnknownParenteralIntravenousIntramuscularSubcutaneous

Species Affected

Cat 21

Dog 11

Most Affected Breeds

Domestic Shorthair 15

Retriever - Labrador 3

Domestic Longhair 3

Cat (unknown) 2

Shih Tzu 1

Rottweiler 1

Shepherd Dog - German 1

Mixed (Dog) 1

Shepherd Dog - Australian 1

Terrier - Boston 1

Most Reported Reactions

Decreased appetite 5

Behavioural disorder NOS 5

Vomiting 4

Hypothermia 3

Death 3

Walking difficulty 3

Not eating 3

Seizure NOS 3

Hyperactivity 3

Elevated temperature 3

Dehydration 2

Sedation prolonged 2

Outcome Breakdown

Recovered/Normal

11 (34.4%)

Ongoing

9 (28.1%)

Outcome Unknown

9 (28.1%)

Died

3 (9.4%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.